206
Views
11
CrossRef citations to date
0
Altmetric
Methodology

Design of Phase 3 Studies Evaluating Vixotrigine for Treatment of Trigeminal Neuralgia

, ORCID Icon, , , , , & ORCID Icon show all
Pages 1601-1609 | Published online: 01 Jul 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Joseph V. Pergolizzi$suffix/text()$suffix/text(), Christopher Gharibo, Peter Magnusson, Frank Breve, Jo Ann LeQuang & Giustino Varrassi. (2022) Pharmacotherapeutic management of trigeminal neuropathic pain: an update. Expert Opinion on Pharmacotherapy 23:10, pages 1155-1164.
Read now
Joshua L. Johnson, Jiansheng Huang, Michael Rooney & Chungang Gu. (2022) Optimal pH 8.5 to 9 for the hydrolysis of vixotrigine and other basic substrates of carboxylesterase-1 in human liver microsomes. Xenobiotica 52:2, pages 105-112.
Read now

Articles from other publishers (9)

Luis Ricardo Hernández & Martín Alejandro Serrano Meneses. 2023. Technology, Science and Culture - A Global Vision, Volume IV. Technology, Science and Culture - A Global Vision, Volume IV.
Swarnalakshmi Raman, Daisuke Ikutame, Kazuo Okura & Yoshizo Matsuka. (2023) Targeted Therapy for Orofacial Pain: A Novel Perspective for Precision Medicine. Journal of Personalized Medicine 13:3, pages 565.
Crossref
Joel Castro, Jessica Maddern, Chun Yuen Chow, Poanna Tran, Irina Vetter, Glenn F. King & Stuart M. Brierley. (2023) The voltage‐gated sodium channel Na V 1 .7 underlies endometriosis‐associated chronic pelvic pain . Journal of Neurochemistry.
Crossref
Marc Sindou & Andrei BrinzeuMarc Sindou & Andrei Brinzeu. 2023. Trigeminal Neuralgias: A Neurosurgical Illustrated Guide. Trigeminal Neuralgias: A Neurosurgical Illustrated Guide 57 61 .
Yutaka Kitano & Tsuyoshi Shinozuka. (2022) Inhibition of Na V 1.7: the possibility of ideal analgesics . RSC Medicinal Chemistry 13:8, pages 895-920.
Crossref
David A. Eagles, Chun Yuen Chow & Glenn F. King. (2020) Fifteen years of Na V 1.7 channels as an analgesic target: Why has excellent in vitro pharmacology not translated into in vivo analgesic efficacy? . British Journal of Pharmacology 179:14, pages 3592-3611.
Crossref
Gary W. Jay & Robert L. Barkin. (2022) Trigeminal neuralgia and persistent idiopathic facial pain (atypical facial pain). Disease-a-Month 68:6, pages 101302.
Crossref
Sascha R. A. Alles & Peter A. Smith. (2021) Peripheral Voltage-Gated Cation Channels in Neuropathic Pain and Their Potential as Therapeutic Targets. Frontiers in Pain Research 2.
Crossref
Stine Maarbjerg & Rafael Benoliel. (2021) The changing face of trigeminal neuralgia—A narrative review. Headache: The Journal of Head and Face Pain 61:6, pages 817-837.
Crossref